Demi Weldon

Demi Weldon is an experienced Executive Director and leader in the biostatistics and data science field, currently leading a global team at AstraZeneca with a focus on lung disease. Previously, Demi held senior roles at Genentech, where they led cross-functional teams for significant FDA advisory meetings and global product development in oncology and hematology. With a background in establishing innovative statistical methodologies at MD Anderson Cancer Center, Demi has contributed to groundbreaking studies and initiatives in personalized medicine. They are also involved as an angel investor with i8 Club and are pursuing advanced degrees in Statistics at Texas A&M University and Rice University.